Literature DB >> 21393357

Offspring sex determines the impact of the maternal ACE I/D polymorphism on maternal glycaemic control during the last weeks of pregnancy.

Berthold Hocher1, Ludwig Schlemm, Hannah Haumann, Jan Rahnenführer, Florian Guthmann, Christian Bamberg, Philipp Kalk, Thiemo Pfab, You-Peng Chen.   

Abstract

UNLABELLED: HYPOTHESIS/
INTRODUCTION: : We recently demonstrated that fetal sex may affect maternal glycaemic control in genetically prone mothers. We tested the hypothesis that fetal sex/fetal Y/X chromosomes might affect maternal glycaemic control during pregnancy depending on the maternal angiotensin converting enzyme (ACE) I/D polymorphism.
MATERIAL AND METHODS: : One thousand, three hundred and thirty-two Caucasian women without pre-existing diabetes and pre-existing hypertension with singleton pregnancies delivering consecutively at the Charité obstetrics department were genotyped. Glycaemic control was analysed by measuring total glycated haemoglobin at birth. Correction for confounding factors and multiple testing was done.
RESULTS: : Maternal ACE I/D polymorphism showed significant interaction with fetal sex concerning maternal total glycated haemoglobin. Total glycated haemoglobin in DD mothers delivering boys was 6.42 ± 0.70% vs. 6.21 ± 0.66% in DD mother delivering girls (p < 0.005), whereas the II carrying mothers showed the opposite effect. II mothers delivering a girl had a higher (p = 0.044) total glycated haemoglobin at birth (6.40 ± 0.80%) compared to II mothers delivering boys (6.21 ± 0.81%). There was no interaction of the ACE I/D polymorphism and fetal sex with respect to new onset proteinuria, new onset edema and pregnancy-induced hypertension.
CONCLUSIONS: : Maternal glycaemic control during the last weeks of pregnancy seems to be influenced by an interaction of the ACE I/D genotyp and fetal sex.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21393357     DOI: 10.1177/1470320310387843

Source DB:  PubMed          Journal:  J Renin Angiotensin Aldosterone Syst        ISSN: 1470-3203            Impact factor:   1.636


  4 in total

1.  Angiotensin-converting enzyme gene insertion/deletion polymorphism with metabolic syndrome in Turkish patients.

Authors:  S Simsek; S Tekes; A Turkyilmaz; A K Tuzcu; F Kılıc; N N Culcu; B Isık; H Akbas
Journal:  J Endocrinol Invest       Date:  2013-05-20       Impact factor: 4.256

Review 2.  Associations Between Fetal Imprinted Genes and Maternal Blood Pressure in Pregnancy.

Authors:  Clive J Petry; Nuria Sanz Marcos; Gracielle Pimentel; M Geoffrey Hayes; Michael Nodzenski; Denise M Scholtens; Ieuan A Hughes; Carlo L Acerini; Ken K Ong; William L Lowe; David B Dunger
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

3.  Epigenetic signatures of gestational diabetes mellitus on cord blood methylation.

Authors:  Larissa Haertle; Nady El Hajj; Marcus Dittrich; Tobias Müller; Indrajit Nanda; Harald Lehnen; Thomas Haaf
Journal:  Clin Epigenetics       Date:  2017-03-27       Impact factor: 6.551

4.  Fetal sex and maternal insulin resistance during mid-pregnancy: a retrospective cohort study.

Authors:  Hiroshi Yamashita; Ichiro Yasuhi; Megumi Koga; So Sugimi; Yasushi Umezaki; Misao Fukuoka; Sachie Suga; Masashi Fukuda; Nobuko Kusuda
Journal:  BMC Pregnancy Childbirth       Date:  2020-09-24       Impact factor: 3.007

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.